Whitehawk Therapeutics, Inc. (WHWK) Financial Statements (2026 and earlier)

Company Profile

Business Address 2 HEADQUARTERS PLAZA
MORRISTOWN, NJ 07960
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:145,70047,200108,800172,600148,98942,605
Cash and cash equivalent37,56828,67062,88839,019148,98942,605
Short-term investments108,12918,56745,957133,541  
Other undisclosed cash, cash equivalents, and short-term investments3(37)(45)40  
Receivables  5,9035,4881,862  
Inventory, net of allowances, customer advances and progress billings  5,3116,4271,861  
Inventory  5,3116,4271,861  
Prepaid expense      510
Other current assets      1,604
Other undisclosed current assets3,3132,8733,8713,7062,283 
Total current assets:149,01361,287124,586180,029151,27244,719
Noncurrent Assets
Operating lease, right-of-use asset  7871,1691,52255764
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization36,8464,80250857122
Intangible asset, including goodwill, after accumulated amortization     3,811 
Intangible asset, excluding goodwill, after accumulated amortization     3,811 
Deposits noncurrent assets      20
Other noncurrent assets1,8141,3991,8662,1782,213 
Total noncurrent assets:1,8179,0327,8374,2086,638206
TOTAL ASSETS:150,83070,319132,423184,237157,91044,925
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:14,51916,80620,20418,44114,8841,799
Employee-related liabilities✕✕✕✕✕ 477
Accounts payable9172,1595,8983,5196,439523
Accrued liabilities13,60214,64714,30614,9228,445471
Other undisclosed accounts payable and accrued liabilities      328
Due to related parties✕✕✕✕ 258 
Other undisclosed current liabilities  2686,19139413167
Total current liabilities:14,51917,07426,39518,83515,2731,867
Noncurrent Liabilities
Long-term debt and lease obligation:     474 
Liabilities, other than long-term debt  7678331,2675,757 
Due to related parties✕✕✕✕ 5,757 
Other liabilities  202    
Operating lease, liability  5658331,267474 
Other undisclosed noncurrent liabilities    5,757  
Total noncurrent liabilities:  7678337,0246,231 
Total liabilities:14,51917,84127,22825,85921,5041,867
Equity
Equity, attributable to parent136,31152,478105,195158,378136,40643,058
Common stock422225
Additional paid in capital489,437385,114374,129361,689279,089189,604
Accumulated other comprehensive income (loss)1201627(115)  
Accumulated deficit(353,250)(332,654)(268,963)(203,198)(142,685)(146,551)
Total equity:136,31152,478105,195158,378136,40643,058
TOTAL LIABILITIES AND EQUITY:150,83070,319132,423184,237157,91044,925

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues 7,14525,98324,35415,2161,12015,000
Cost of revenue (88,026)(3,024)(2,809)(1,335)(171) 
Cost of product and service sold (760)(3,024)(2,809)(1,335)  
Provision for loan, lease, and other losses     (171) 
Gross profit: (80,881)22,95921,54513,88194915,000
Operating expenses(33,519)(90,417)(93,478)(76,562)(112,337)(21,357)
Other undisclosed operating income     171 
Operating loss:(114,400)(67,458)(71,933)(62,681)(111,217)(6,357)
Nonoperating income93,8043,7676,1682,1681,1292,042
Other nonoperating income93,8043,7676,1682,1681,1291,814
Interest and debt expense  (154)(231)(230)196 
Loss from continuing operations before equity method investments, income taxes:(20,596)(63,845)(65,996)(60,743)(109,892)(4,315)
Other undisclosed income (loss) from continuing operations before income taxes  154231230(196) 
Loss from continuing operations before income taxes:(20,596)(63,691)(65,765)(60,513)(110,088)(4,315)
Income tax expense     (2) 
Loss from continuing operations:(20,596)(63,691)(65,765)(60,513)(110,090)(4,315)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(110,090)(4,315)
Net loss available to common stockholders, diluted:(20,596)(63,691)(65,765)(60,513)(110,090)(4,315)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(20,596)(63,691)(65,765)(60,513)(110,090)(4,315)
Other comprehensive loss    (115)  
Comprehensive loss:(20,596)(63,691)(65,765)(60,628)(110,090)(4,315)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent104(11)142 (647) 
Comprehensive loss, net of tax, attributable to parent:(20,492)(63,702)(65,623)(60,628)(110,737)(4,315)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: